CTV announced today that it has renewed Canada’s most-watched original drama series, Transplant, for a third season. Produced by Sphere Media in association with CTV and Universal International Studios, a division of Universal Studio Group, Season 3 of the CTV Original drama consists of 13 one-hour episodes.
New episodes of Transplant‘s second season continue on Mondays at 10 p.m. ET/PT on CTV before moving to its new timeslot of Tuesdays at 10 p.m. ET/PT beginning March 1.
Filming on Season 3 will take place in Montréal, with Hamza Haq (My Salinger Year) reprising his role as Dr. Bashir Hamed — known to most as Bash — a talented doctor and Syrian refugee who fled to Canada and was granted a second chance to practice Emergency Medicine at York Memorial Hospital in Toronto.
The series continues to resonate with audiences across Canada as the most-watched Canadian drama series with total viewers and in the key A25-54 demo, with a current season average of 1.1 million viewers.
Transplant has also had international success, having been embraced by U.S. viewers on NBC, with Season 2 set to premiere March 6 at 10 p.m. ET. The drama has also launched across the UK, Australia, Spain, Germany, the Netherlands, and more.
“Viewers around the world have embraced Transplant, and we look forward to bringing this exceptional cast back as we continue to tell the stories of York Memorial Hospital,” said Justin Stockman, Vice-President, Content Development & Programming at Bell Media.
He added: “With our partners at Sphere Media and Universal International Studios, Canadians can look forward to more of the emotional and gripping narratives they have come to love.”
“It is once again an immense privilege for us to continue the Transplant adventure with such great partners as Bell Media and Universal International Studios,” said Jocelyn Deschênes, President, Chief Executive Producer International – Original Fiction Content at Sphere Media.
She added: “Transplant has touched the hearts of many viewers around the world, and we’re confident that Season 3 will grasp their attention even more.”
Transplant has also received critical acclaim and recognition, including nine 2022 Canadian Screen Award nominations for Best Drama Series, Best Lead Actor, Drama Series for Hamza Haq, Best Lead Actress, Drama Series for Laurence Leboeuf, and Best Supporting Actress, Drama for Ayisha Issa.
Season 2 stars Hamza Haq as Dr. Bashir “Bash” Hamed; Laurence Leboeuf (19-2) as Dr. Magalie “Mags” Leblanc; John Hannah (Marvel’s Agents of S.H.I.E.L.D.) as Dr. Jed Bishop; Ayisha Issa (Polar) as Dr. June Curtis; and Jim Watson (Designated Survivor) as Dr. Theo Hunter.
Also starring are Sirena Gulamgaus (Orphan Black) as Amira Hamed; Torri Higginson (Dark Matter, This Life) as Claire Malone; Linda Smith (19-2) as Dr. Wendy Atwater; Kenny Wong (Pretty Hard Cases) as Arnold De Luca; and Sugith Varughese (Kim’s Convenience) as Dr. Aajay Singh.
The series is created by Joseph Kay who also serves as executive producer and showrunner. For Sphere Media, the executive producers are Bruno Dubé, Jocelyn Deschênes, Josée Vallée, Rachel Langer, and Stefan Pleszczynski.
For CTV, Mitch Geddes is the Production Executive; Sarah Fowlie is the Head of Production, Original Programming; Carlyn Klebuc is the General Manager of Original Programming; and Pat DiVittorio is the Vice-President of CTV and Specialty Programming.
Justin Stockman is Vice-President, Content Development & Programming at Bell Media. Karine Moses is Senior Vice-President, Content Development & News, Bell Media and Vice Chair, Québec, Bell.
All distribution rights for Transplant are handled by NBCUniversal Global Distribution. The series is produced with the participation of the Canada Media Fund, provincial and federal tax credits, and the Bell Fund.
Mirko Parlevliet has been reporting on the entertainment industry since 1998 and founded Vital Thrills in 2018 to cover the latest news on streaming, movies, TV, and video games.